Labcorp Holdings, Inc. (LH)
273.26
-1.46
(-0.53%)
USD |
NYSE |
Apr 09, 16:00
273.18
-0.08
(-0.03%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 22.52B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 19.84% |
| Valuation | |
| PE Ratio | 26.13 |
| PE Ratio (Forward) | |
| PS Ratio | 1.641 |
| Price to Book Value | 2.612 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.72 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.7571 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 34.60% |
Profile
| Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates through the Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS) segments. The Dx segment includes routine and specialty esoteric testing. The BLS segment consists of central laboratory and ED businesses. The company was founded in 1995 and is headquartered in Burlington, NC. |
| URL | http://www.labcorp.com |
| Investor Relations URL | https://ir.labcorp.com |
| HQ State/Province | North Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Apr. 30, 2026 |
| Last Earnings Release | Feb. 17, 2026 |
| Next Ex-Dividend Date | May. 29, 2026 |
| Last Ex-Dividend Date | Feb. 27, 2026 |
Profile
| Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates through the Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS) segments. The Dx segment includes routine and specialty esoteric testing. The BLS segment consists of central laboratory and ED businesses. The company was founded in 1995 and is headquartered in Burlington, NC. |
| URL | http://www.labcorp.com |
| Investor Relations URL | https://ir.labcorp.com |
| HQ State/Province | North Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Apr. 30, 2026 |
| Last Earnings Release | Feb. 17, 2026 |
| Next Ex-Dividend Date | May. 29, 2026 |
| Last Ex-Dividend Date | Feb. 27, 2026 |